Picture of Torrent Pharmaceuticals logo

TORNTPHARM — Torrent Pharmaceuticals News Story

0.000.00%
in flag iconLast trade - 00:00
HealthcareConservativeLarge CapHigh Flyer

India's Torrent Pharma hits record high on Q2 profit jump

** Torrent Pharma TORP.NS rises 5.9% to record high of 3,809 rupees; set for biggest single-day pct gain since May 2023

** Drugmaker's Q2 profit jumps 30.5% y/y, driven by strong domestic demand for its cardiovascular, anti-diabetic drugs

** Revenue grows 12% y/y on higher domestic sales, accounting for more than half of total

** JP Morgan cites growth driving Indian market, recovery in Brazil, potential semaglutide launch next year, JB Pharma deal synergies as multiple catalysts for co

** Jefferies says co "gold standard of consistency" given its domestic-focused approach with steady, predictable growth

** Maintains "buy"; raises PT by 100 rupees to 4,300 rupees

** More than 704,000 shares traded, 3x their 30-day avg

** Stock rated "buy" on avg; median PT is 4,000 rupees, per data compiled by LSEG

** YTD, TORP gains 13.4%

 (Reporting by Urvi Dugar in Bengaluru)

 ((UrviManoj.Dugar@thomsonreuters.com;))

Recent news on Torrent Pharmaceuticals

See all news